[Macrophage specific MRI imaging for antigen induced arthritides. A potential new strategy for the diagnosis of rheumatoid arthritis]
Related Experiment Video
Updated: Jul 17, 2026
In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis
Published on: October 20, 2013
G H Simon1, H E Daldrup-Link, E J Rummeny
1Institut für Radiologie, Technische Universität München, Klinikum rechts der Isar, München. gerhardhsimon@hotmail.com
Purpose:
The present work describes the potential of iron oxides for the detection of macrophages in synovitis in experimental, antigen-induced arthritis.
Methods:
The pivotal role of macrophages in rheumatoid arthritis (RA) in humans and in antigen-induced arthritis (AIA) in animal models is discussed. The latter appear to be very similar in many aspects to the human RA. We show the potential for iron oxide-enhanced magnetic resonance imaging (MRI) to determine the macrophage content in the arthritic synovial membranes. The results of our own research, as well as those of other research groups, are presented and discussed.
Results:
MRI after the intravenous (i.v.) administration of iron oxides enables the depiction of macrophage content in arthritic synovial membranes in AIA through the effects of the intracellular compartmentalisation of iron oxide particles. These effects can be demonstrated in 24-h delayed images after i.v. contrast application, on T2-weighted spin-echo or turbo-spin-echo sequences, and especially on T2*-weighted gradient-echo sequences. The signal effects are not only apparent in high field strength (4.7 Tesla) but also on 1.5 Tesla clinical scanners.
Conclusions And Perspectives:
The use of iron oxides enables the determination of the macrophage content in synovitis in animals with AIA. This parameter represents a potential marker to determine disease activity, and possibly represents a marker to evaluate the effectiveness of specific therapies in human RA. Current knowledge of iron oxide-enhanced MRI is limited to animal models. The clinical evaluation of this new method in patients with RA has not yet been performed. However, based on the considerations presented here, significant progress in the diagnostic work-up of RA can be expected.
Insights
Iron oxides enable detection of macrophages in synovitis using magnetic resonance imaging (MRI) in experimental antigen-induced arthritis (AIA). This technique may serve as a marker for disease activity and therapy evaluation in human rheumatoid arthritis (RA).
Area of Science:
- Biomedical imaging
- Immunology
- Materials science
Context:
- Macrophages play a critical role in rheumatoid arthritis (RA) and antigen-induced arthritis (AIA).
- AIA in animal models closely mimics human RA.
- Accurate assessment of macrophage content is crucial for understanding disease progression and treatment efficacy.
Purpose:
- To investigate the potential of iron oxides for detecting macrophages in synovitis.
- To evaluate iron oxide-enhanced magnetic resonance imaging (MRI) for quantifying macrophage content in arthritic synovial membranes.
- To explore the utility of this method as a potential biomarker for disease activity and therapeutic response in RA.
Summary:
- Intravenous administration of iron oxides allows for the visualization of macrophage content in arthritic synovial membranes via MRI.
- Signal changes are observable on T2- and T2*-weighted sequences, even on clinical 1.5 Tesla scanners.
- Intracellular compartmentalization of iron oxide particles influences the MRI signal, enabling macrophage detection.
Impact:
- Iron oxides can determine macrophage content in synovitis, serving as a potential marker for disease activity in AIA.
- This method may offer a novel approach for evaluating the effectiveness of specific therapies in human RA.
- While currently limited to animal models, iron oxide-enhanced MRI holds promise for advancing the diagnostic work-up of RA.
